Head and neck hemangiomas of infancy

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Hemangiomas are the most common benign tumor in infancy, affecting approximately 10% of infants. More than half of hemangiomas involve the head and neck. Increased understanding of hemangiomas has come about from identification of immunohistochemical markers, developmental defects associated with certain hemangiomas, and morphologic and classification schemes (focal versus segmental). RECENT FINDINGS: Immunohistochemical markers have been identified which are specific to hemangiomas in all phases of development and involution. Morphologic subtypes and anatomic locations have been identified that place an infant at higher risk for complications from the hemangioma. Hemangiomas associated with other developmental anomalies have been identified, which help guide the treating physician to tease out which infants will need more complete systemic investigations or imaging. Importantly for surgeons, studies have continued to identify which lesions may benefit from early intervention, either surgical or medical. SUMMARY: While full understanding of the mechanisms that turn on and turn off hemangiomas of infancy is not complete, progress has been made in identification of markers, subtypes at increased risk for complications, and in treatment. With continued work in these areas, we have increased knowledge of treatment options, optimal timing of surgical intervention, and ultimately, preventive options.

Original languageEnglish (US)
Pages (from-to)397-405
Number of pages9
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Volume14
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Hemangioma
Neck
Head
Physicians
Therapeutics

Keywords

  • Glut-1
  • Hemangiomas of infancy
  • PHACE(S) association
  • Segmental hemangioma

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Head and neck hemangiomas of infancy. / Macarthur, Carol.

In: Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 14, No. 6, 12.2006, p. 397-405.

Research output: Contribution to journalArticle

@article{3dfbd398f567452bb747c57a66a0d7e9,
title = "Head and neck hemangiomas of infancy",
abstract = "PURPOSE OF REVIEW: Hemangiomas are the most common benign tumor in infancy, affecting approximately 10{\%} of infants. More than half of hemangiomas involve the head and neck. Increased understanding of hemangiomas has come about from identification of immunohistochemical markers, developmental defects associated with certain hemangiomas, and morphologic and classification schemes (focal versus segmental). RECENT FINDINGS: Immunohistochemical markers have been identified which are specific to hemangiomas in all phases of development and involution. Morphologic subtypes and anatomic locations have been identified that place an infant at higher risk for complications from the hemangioma. Hemangiomas associated with other developmental anomalies have been identified, which help guide the treating physician to tease out which infants will need more complete systemic investigations or imaging. Importantly for surgeons, studies have continued to identify which lesions may benefit from early intervention, either surgical or medical. SUMMARY: While full understanding of the mechanisms that turn on and turn off hemangiomas of infancy is not complete, progress has been made in identification of markers, subtypes at increased risk for complications, and in treatment. With continued work in these areas, we have increased knowledge of treatment options, optimal timing of surgical intervention, and ultimately, preventive options.",
keywords = "Glut-1, Hemangiomas of infancy, PHACE(S) association, Segmental hemangioma",
author = "Carol Macarthur",
year = "2006",
month = "12",
doi = "10.1097/MOO.0b013e328010ba6b",
language = "English (US)",
volume = "14",
pages = "397--405",
journal = "Current Opinion in Otolaryngology and Head and Neck Surgery",
issn = "1068-9508",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Head and neck hemangiomas of infancy

AU - Macarthur, Carol

PY - 2006/12

Y1 - 2006/12

N2 - PURPOSE OF REVIEW: Hemangiomas are the most common benign tumor in infancy, affecting approximately 10% of infants. More than half of hemangiomas involve the head and neck. Increased understanding of hemangiomas has come about from identification of immunohistochemical markers, developmental defects associated with certain hemangiomas, and morphologic and classification schemes (focal versus segmental). RECENT FINDINGS: Immunohistochemical markers have been identified which are specific to hemangiomas in all phases of development and involution. Morphologic subtypes and anatomic locations have been identified that place an infant at higher risk for complications from the hemangioma. Hemangiomas associated with other developmental anomalies have been identified, which help guide the treating physician to tease out which infants will need more complete systemic investigations or imaging. Importantly for surgeons, studies have continued to identify which lesions may benefit from early intervention, either surgical or medical. SUMMARY: While full understanding of the mechanisms that turn on and turn off hemangiomas of infancy is not complete, progress has been made in identification of markers, subtypes at increased risk for complications, and in treatment. With continued work in these areas, we have increased knowledge of treatment options, optimal timing of surgical intervention, and ultimately, preventive options.

AB - PURPOSE OF REVIEW: Hemangiomas are the most common benign tumor in infancy, affecting approximately 10% of infants. More than half of hemangiomas involve the head and neck. Increased understanding of hemangiomas has come about from identification of immunohistochemical markers, developmental defects associated with certain hemangiomas, and morphologic and classification schemes (focal versus segmental). RECENT FINDINGS: Immunohistochemical markers have been identified which are specific to hemangiomas in all phases of development and involution. Morphologic subtypes and anatomic locations have been identified that place an infant at higher risk for complications from the hemangioma. Hemangiomas associated with other developmental anomalies have been identified, which help guide the treating physician to tease out which infants will need more complete systemic investigations or imaging. Importantly for surgeons, studies have continued to identify which lesions may benefit from early intervention, either surgical or medical. SUMMARY: While full understanding of the mechanisms that turn on and turn off hemangiomas of infancy is not complete, progress has been made in identification of markers, subtypes at increased risk for complications, and in treatment. With continued work in these areas, we have increased knowledge of treatment options, optimal timing of surgical intervention, and ultimately, preventive options.

KW - Glut-1

KW - Hemangiomas of infancy

KW - PHACE(S) association

KW - Segmental hemangioma

UR - http://www.scopus.com/inward/record.url?scp=33750936283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750936283&partnerID=8YFLogxK

U2 - 10.1097/MOO.0b013e328010ba6b

DO - 10.1097/MOO.0b013e328010ba6b

M3 - Article

VL - 14

SP - 397

EP - 405

JO - Current Opinion in Otolaryngology and Head and Neck Surgery

JF - Current Opinion in Otolaryngology and Head and Neck Surgery

SN - 1068-9508

IS - 6

ER -